JPS59190226A - 二価三価鉄塩およびその製造方法 - Google Patents
二価三価鉄塩およびその製造方法Info
- Publication number
- JPS59190226A JPS59190226A JP58064298A JP6429883A JPS59190226A JP S59190226 A JPS59190226 A JP S59190226A JP 58064298 A JP58064298 A JP 58064298A JP 6429883 A JP6429883 A JP 6429883A JP S59190226 A JPS59190226 A JP S59190226A
- Authority
- JP
- Japan
- Prior art keywords
- trivalent iron
- divalent
- bivalent
- salts
- trivalent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002505 iron Chemical class 0.000 title claims abstract description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 52
- 229910052742 iron Inorganic materials 0.000 claims abstract description 26
- 239000007864 aqueous solution Substances 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 4
- 239000003513 alkali Substances 0.000 claims abstract description 3
- 150000002484 inorganic compounds Chemical class 0.000 claims description 2
- 229910010272 inorganic material Inorganic materials 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- 229940125898 compound 5 Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 159000000014 iron salts Chemical class 0.000 abstract description 11
- 239000000126 substance Substances 0.000 abstract description 8
- 150000003839 salts Chemical class 0.000 abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
- 230000009471 action Effects 0.000 abstract description 6
- 230000002829 reductive effect Effects 0.000 abstract description 6
- 230000000840 anti-viral effect Effects 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 abstract description 2
- 239000013078 crystal Substances 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 150000002500 ions Chemical class 0.000 abstract description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 abstract description 2
- -1 FeCl3 Chemical class 0.000 abstract 2
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 22
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 150000002632 lipids Chemical class 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 230000007797 corrosion Effects 0.000 description 10
- 238000005260 corrosion Methods 0.000 description 10
- 150000002506 iron compounds Chemical class 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000002689 soil Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 241000227653 Lycopersicon Species 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 238000009335 monocropping Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 229940035936 ubiquinone Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000237519 Bivalvia Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000008585 Pinus thunbergii Nutrition 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 235000020639 clam Nutrition 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000010981 drying operation Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 229910010271 silicon carbide Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 235000005638 Austrian pine Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical class [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000519695 Ilex integra Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000008565 Pinus banksiana Nutrition 0.000 description 1
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 1
- 244000019397 Pinus jeffreyi Species 0.000 description 1
- 235000008578 Pinus strobus Nutrition 0.000 description 1
- 241000218686 Pinus thunbergii Species 0.000 description 1
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- LTVDFSLWFKLJDQ-DKGMKSHISA-N alpha-Tocopherolquinone Natural products CC(C)CCC[C@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O LTVDFSLWFKLJDQ-DKGMKSHISA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229940021013 electrolyte solution Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 230000009701 normal cell proliferation Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Compounds Of Iron (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cultivation Of Plants (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58064298A JPS59190226A (ja) | 1983-04-11 | 1983-04-11 | 二価三価鉄塩およびその製造方法 |
| JP1270700A JPH0761875B2 (ja) | 1983-04-11 | 1989-10-17 | 活性物質の製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58064298A JPS59190226A (ja) | 1983-04-11 | 1983-04-11 | 二価三価鉄塩およびその製造方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1270700A Division JPH0761875B2 (ja) | 1983-04-11 | 1989-10-17 | 活性物質の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59190226A true JPS59190226A (ja) | 1984-10-29 |
| JPH0427171B2 JPH0427171B2 (enrdf_load_stackoverflow) | 1992-05-11 |
Family
ID=13254197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58064298A Granted JPS59190226A (ja) | 1983-04-11 | 1983-04-11 | 二価三価鉄塩およびその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59190226A (enrdf_load_stackoverflow) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61247317A (ja) * | 1985-04-22 | 1986-11-04 | 日本植生株式会社 | 土壌改良用目土 |
| JPS6354936A (ja) * | 1986-08-25 | 1988-03-09 | Masami Oe | アルミナ―鉄塩複合体の製造方法 |
| JPH01311007A (ja) * | 1988-06-08 | 1989-12-15 | I B Ii:Kk | 植物の処理方法 |
| JPH02113093A (ja) * | 1988-10-20 | 1990-04-25 | Shizen:Kk | 食品用油処理剤 |
| JPH02167879A (ja) * | 1988-12-20 | 1990-06-28 | Shizen:Kk | 二価三価複合鉄塩配合肥料 |
| JPH02208398A (ja) * | 1989-02-09 | 1990-08-17 | Shizen:Kk | 香料物質処理剤 |
| WO1991017957A1 (fr) * | 1990-05-22 | 1991-11-28 | I.B.E. Co., Ltd. | Composition de sel ferreux |
| JPH0454101A (ja) * | 1990-06-25 | 1992-02-21 | Tetsuo Takano | 移植用腎臓の保存方法及び保存装置 |
| WO1995022254A1 (en) * | 1994-02-17 | 1995-08-24 | Merck Patent Gmbh | Antiviral or antifungal composition and method |
| WO1995035113A1 (de) * | 1994-06-20 | 1995-12-28 | Thomas Bruns | VERWENDUNG VON EISEN (III)-OXID (Fe2O3) BEI IMMUNSCHWÄCHE, INSBESONDERE AIDS |
| EP0896792A1 (en) * | 1997-08-13 | 1999-02-17 | Julphar Pharma GmbH | Antiviral agent |
| WO2001047815A1 (fr) * | 1999-12-26 | 2001-07-05 | Institute For State Physics Of Natural Materials | Nouvelles compositions aqueuses et utilisation de ces compositions |
| WO2001093879A1 (fr) * | 2000-06-06 | 2001-12-13 | I.B.E. Co., Ltd. | Agents biologiquement actifs et medicaments |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6861264B1 (ja) | 2019-11-19 | 2021-04-21 | 慶昌 木島 | 組成物 |
-
1983
- 1983-04-11 JP JP58064298A patent/JPS59190226A/ja active Granted
Non-Patent Citations (1)
| Title |
|---|
| ENCYCLOPEDIA OF CHEMICAL REACTIONS=1951 * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61247317A (ja) * | 1985-04-22 | 1986-11-04 | 日本植生株式会社 | 土壌改良用目土 |
| JPS6354936A (ja) * | 1986-08-25 | 1988-03-09 | Masami Oe | アルミナ―鉄塩複合体の製造方法 |
| JPH01311007A (ja) * | 1988-06-08 | 1989-12-15 | I B Ii:Kk | 植物の処理方法 |
| JPH02113093A (ja) * | 1988-10-20 | 1990-04-25 | Shizen:Kk | 食品用油処理剤 |
| JPH02167879A (ja) * | 1988-12-20 | 1990-06-28 | Shizen:Kk | 二価三価複合鉄塩配合肥料 |
| JPH02208398A (ja) * | 1989-02-09 | 1990-08-17 | Shizen:Kk | 香料物質処理剤 |
| WO1991017957A1 (fr) * | 1990-05-22 | 1991-11-28 | I.B.E. Co., Ltd. | Composition de sel ferreux |
| JPH0454101A (ja) * | 1990-06-25 | 1992-02-21 | Tetsuo Takano | 移植用腎臓の保存方法及び保存装置 |
| WO1995022254A1 (en) * | 1994-02-17 | 1995-08-24 | Merck Patent Gmbh | Antiviral or antifungal composition and method |
| US6187316B1 (en) | 1994-02-17 | 2001-02-13 | Merck Patent Gmbh | Antiviral or antifungal composition and method |
| WO1995035113A1 (de) * | 1994-06-20 | 1995-12-28 | Thomas Bruns | VERWENDUNG VON EISEN (III)-OXID (Fe2O3) BEI IMMUNSCHWÄCHE, INSBESONDERE AIDS |
| EP0896792A1 (en) * | 1997-08-13 | 1999-02-17 | Julphar Pharma GmbH | Antiviral agent |
| WO1999008536A1 (en) * | 1997-08-13 | 1999-02-25 | Julphar Pharma Gmbh | Antiviral agent |
| WO2001047815A1 (fr) * | 1999-12-26 | 2001-07-05 | Institute For State Physics Of Natural Materials | Nouvelles compositions aqueuses et utilisation de ces compositions |
| WO2001093879A1 (fr) * | 2000-06-06 | 2001-12-13 | I.B.E. Co., Ltd. | Agents biologiquement actifs et medicaments |
| AU2001262699B2 (en) * | 2000-06-06 | 2006-05-04 | I.B.E. Co., Ltd. | Biologically active agents and drugs |
| KR100704566B1 (ko) | 2000-06-06 | 2007-04-06 | 유겐가이샤 아이.비.이 | 철염의 처리 방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0427171B2 (enrdf_load_stackoverflow) | 1992-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS59190226A (ja) | 二価三価鉄塩およびその製造方法 | |
| CN107902736B (zh) | 复合絮凝抑藻剂的制备方法及复合絮凝抑藻剂 | |
| JP2008136945A (ja) | 天然ミネラル含有剤、及びそれらの製造方法 | |
| JPS60186581A (ja) | 二価三価鉄塩配合物およびその製造法 | |
| CN101400262A (zh) | 新植酸柠檬酸化合物及其制备方法 | |
| JP2017160447A (ja) | ベンゼンポリカルボン酸化合物及びその薬剤としての使用 | |
| JP4598227B2 (ja) | 放射線および化学療法における感受性増強剤である化合物、並びにそれらの製造方法および使用 | |
| CN106834399A (zh) | 一种来源于厚壳贻贝闭壳肌的降压肽 | |
| RU2108797C1 (ru) | Способ получения антивирусного препарата на основе днк | |
| KR102305089B1 (ko) | 멍게체액 추출물의 제조방법 | |
| JP2713725B2 (ja) | エチレンジアミン化合物−鉄錯体 | |
| JPH03187921A (ja) | 活性物質の製造方法 | |
| JPH05310728A (ja) | 変性フミン酸塩の製造方法とその使用 | |
| RU2238735C1 (ru) | Средство для литолиза мочевых камней и способ его получения | |
| JP3107110B2 (ja) | 微生物を用いるテトラピロール化合物の製造方法 | |
| TW541286B (en) | Novel aqueous composition and use of the same | |
| JPH0380986A (ja) | 四三酸化鉄含有水処理剤 | |
| CN108948140B (zh) | 华法林-4-O-乙酰-Arg-AA十一种化合物,其合成,活性和应用 | |
| JPS6181776A (ja) | 藍藻類の製造方法 | |
| EP0230956B1 (de) | Verfahren zur Gewinnung und Herstellung eines pasteurisierten Präparates von alpha2-Antiplasmin | |
| JP2001139478A (ja) | コーラルサンドからの微量ミネラル成分抽出化合物 | |
| JPH02302326A (ja) | 活性物質の製造方法 | |
| JPH049387A (ja) | ４―ヒドロキシフェニルメチルオキサゾピロロキノリン類 | |
| DE2524822C3 (de) | Neutrale Protease, Verfahren zu ihrer Herstellung und ihre Verwendung zum Aufschluß von animalem Gewebe und zur Suspensionszellkultur | |
| JPH01311007A (ja) | 植物の処理方法 |